Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Excenen PharmaTech
Guangzhou, Guangdong, Chinaexcenen.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Excenen PharmaTech is not a clinical-stage developer; it specializes in the synthesis and supply of small molecule inhibitors and chemical building blocks for pharmaceutical research, with no reported proprietary clinical results[1][3][5][7][9][10].
- Modalities
- Small molecule
- Industry
- Drug Discovery Services
02
Partnerships
Janssen (Johnson & Johnson)GileadAbbVieAcademic collaborations with Duke University, University of Chicago, University of Barcelona, University of Pécs[1]
Beyond the preview
Go deeper on Excenen PharmaTech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Excenen PharmaTech.